Glycan Therapeutics is a biotech company located in Raleigh, NC, specializing in synthesizing carbohydrate-based medicines, research reagents and diagnostics. Glycan Therapeutics offers innovative solutions for design, synthesis, analysis, and validation of carbohydrates specifically heparan sulfate and chondroitin sulfate. Glycan's active therapeutic development program is focused on anticoagulant and anti-inflammatory assets.